Kindred Healthcare (NYSE: KND) shareholders approved the sale of the company’s home health and hospice business to insurance giant Humana (NYSE: HUM) and two private equity groups. The approval comes after some contention among shareholders. One investor with a 5.8% stake in Louisville-based Kindred, Brigade Capital, sued to block the merger. The suit was dismissed […]
A scheduled shareholder vote to sell Kindred Healthcare (NYSE: KND) will move forward after a judge dismissed a lawsuit by a major shareholder. Brigade Capital Management, a New York-based private equity firm with a 5.8% stake in Louisville-based Kindred, sued the health care provider in an attempt to delay or block the vote to sell the […]
A major Kindred Healthcare (NYSE: KND) shareholder on Tuesday continued to forcefully protest the company’s planned sale to Humana and private equity firms, arguing in a publicly released letter that the deal would hurt shareholders but line the pockets of Kindred’s directors and top executives. New York-based Brigade Capital Management has a 5.8% stake in […]
Happy Monday, Home Health Care News readers. Get a jump-start on your week ahead by getting caught up on headlines that caught our eye, and review our top stories from last week. At top of mind for many in the industry is the latest on the acquisition of Kindred Health at Home (NYSE: KND) by […]
As the acquisition of Kindred Healthcare’s (NYSE: KND) home health care business proceeds, one major shareholder is ramping up its fight against the deal. Brigade Capital, a New York-based private equity firm with a 5.8% stake in Kindred, has filed a lawsuit to stop the planned acquisition. The lawsuit, which seeks to stop the merger […]
Since a major shareholder of Kindred Healthcare (NYSE: KND) announced its opposition to a $4.1 billion takeover deal by Humana (NYSE: HUM), the nation’s largest home health care provider has remained mum. Brigade Capital, a New York-based private equity firm which owns a 5.8% stake in Kindred, said it would vote against the transaction under its current […]
A large shareholder of Kindred Healthcare (NYSE: KND) announced its opposition to the company’s recently announced acquisition deal with Humana (NYSE: HUM). Brigade Capital , a New York-based private equity firm with a 5.8% stake in Kindred, opposed the deal on December 27, stating the $9 share price for Kindred is “inadequate.” Humana, along with […]
By continuing to use the site, you agree to the use of cookies. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. For more information, see our cookie policy
